logo
Select company
Select metric
$ 248.73MShareholders Equity
VS
Market
45
Sector
67
Industry
76
History
90
$ 4.72Close
$ 1.13 - $ 5.34 52-Week Range
Ticker Information

Ticker

TSHA

Company Name

TAYSHA GENE THERAPIES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TAYSHA GENE THERAPIES INC - Shareholders Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TSHA - Equity Historical data
DateShareholders Equity
6/30/2025$ 248.73M
3/31/2025$ 55.06M
12/31/2024$ 71.53M
9/30/2024$ 88.8M
6/30/2024$ 108.87M
3/31/2024$ 53.85M
12/31/2023$ 74.94M
9/30/2023$ -49.11M
6/30/2023$ -37.11M
3/31/2023$ -14.95M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TAYSHA GENE THERAPIES INC's latest trailing twelve months (TTM) Equity stands at $ 267.64M.
  • Over the past 5 years, TAYSHA GENE THERAPIES INC's average Equity has been $ 93.01M.
  • The median Equity for TAYSHA GENE THERAPIES INC during this period was $ 73.23M
  • TAYSHA GENE THERAPIES INC reached its highest Equity over the past 5 years at $ 267.64M.
  • The lowest Equity recorded by TAYSHA GENE THERAPIES INC in the same timeframe $ -49.11M

TAYSHA GENE THERAPIES INC's Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Equity Benchmarks
CompanyEquity
RLAY : RELAY THERAPEUTICS INC $ 665.66MPRAX : PRAXIS PRECISION MEDICINES INC $ 404.22MLENZ : LENZ THERAPEUTICS INC $ 206.37MDNTH : DIANTHUS THERAPEUTICS INC $ 303.08MIMNM : IMMUNOME INC $ 269.27MTNXP : TONIX PHARMACEUTICALS HOLDING CORP $ 168MPRME : PRIME MEDICINE INC $ 60.86MNUVB : NUVATION BIO INC $ 372.91MPGEN : PRECIGEN INC $ -36.78MATAI : ATAI LIFE SCIENCES NV $ 143.74M

Definition of Shareholders Equity

[Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.

TSHA - Shareholders Equity, Last 5 years

$ -49.11M

Minimum

Sep 30, 2023

$ 267.64M

Maximum

Sep 30, 2020

$ 93.01M

Average

$ 73.23M

Median

Equity Benchmark Analysis

The chart above depicts the distribution of Equity for companies in the Total Stock Market. The average Equity of the companies is $ 384M with a standard deviation of $ 548.41M.
The following table provides additional summary stats:
Equity in the Market:
filtered constituents3.47K
min$ -1.4B
max$ 2.14B
average$ 384M
median$ 165.72M
std$ 548.41M